In a win for Red Bank, N.J.-based ProventionBio, the FDA approved its drug Tzield Nov. 17, marking the first approved therapy to delay the onset of Type 1 diabetes.
Read the full post on Becker's Hospital Review - Healthcare News
FDA greenlights 1st drug to delay onset of Type 1 diabetes
